NCT00688623
- Conditions
- Adenocarcinoma, Advanced and Metastatic Silent Neuro-Endocrine Tumors, Carcinoid Tumor, +13 more
- Locations
-
- Novartis Investigative Site Bordeaux, France
- Novartis Investigative Site Lyon, France
- Novartis Investigative Site Marseille, France
- Novartis Investigative Site Paris, France